JPS60193955A - 環式不飽和アミド置換エ−テル化合物及びその製造方法 - Google Patents

環式不飽和アミド置換エ−テル化合物及びその製造方法

Info

Publication number
JPS60193955A
JPS60193955A JP59046532A JP4653284A JPS60193955A JP S60193955 A JPS60193955 A JP S60193955A JP 59046532 A JP59046532 A JP 59046532A JP 4653284 A JP4653284 A JP 4653284A JP S60193955 A JPS60193955 A JP S60193955A
Authority
JP
Japan
Prior art keywords
acrylamidobutoxy
group
bis
butylcyacrylamide
butylcoacrylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59046532A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0573739B2 (https=
Inventor
Hiroshi Ito
博 伊藤
Atsuhiko Nitta
新田　敦彦
Tomio Tanaka
田中　富夫
Hideo Kamio
神尾　秀雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP59046532A priority Critical patent/JPS60193955A/ja
Priority to CA000475877A priority patent/CA1244012A/en
Priority to US06/708,568 priority patent/US4649219A/en
Priority to DE8585301695T priority patent/DE3580293D1/de
Priority to EP85301695A priority patent/EP0155177B1/en
Priority to KR1019850001614A priority patent/KR870000958B1/ko
Publication of JPS60193955A publication Critical patent/JPS60193955A/ja
Publication of JPH0573739B2 publication Critical patent/JPH0573739B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP59046532A 1984-03-13 1984-03-13 環式不飽和アミド置換エ−テル化合物及びその製造方法 Granted JPS60193955A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP59046532A JPS60193955A (ja) 1984-03-13 1984-03-13 環式不飽和アミド置換エ−テル化合物及びその製造方法
CA000475877A CA1244012A (en) 1984-03-13 1985-03-06 Unsaturated cyclic amido-substituted ether compounds and preparation process thereof
US06/708,568 US4649219A (en) 1984-03-13 1985-03-06 Unsaturated cyclic amido-substituted ether compounds and preparation process thereof
DE8585301695T DE3580293D1 (de) 1984-03-13 1985-03-12 Ungesaettigte amido-substituierte cyclische aethern-verbindungen und verfahren zu ihrer herstellung.
EP85301695A EP0155177B1 (en) 1984-03-13 1985-03-12 Unsaturated cyclic amido-substituted ether compounds and preparation process thereof
KR1019850001614A KR870000958B1 (ko) 1984-03-13 1985-03-13 불포화된 고리형 아미도-치환된 에테르 화합물의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59046532A JPS60193955A (ja) 1984-03-13 1984-03-13 環式不飽和アミド置換エ−テル化合物及びその製造方法

Publications (2)

Publication Number Publication Date
JPS60193955A true JPS60193955A (ja) 1985-10-02
JPH0573739B2 JPH0573739B2 (https=) 1993-10-15

Family

ID=12749894

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59046532A Granted JPS60193955A (ja) 1984-03-13 1984-03-13 環式不飽和アミド置換エ−テル化合物及びその製造方法

Country Status (6)

Country Link
US (1) US4649219A (https=)
EP (1) EP0155177B1 (https=)
JP (1) JPS60193955A (https=)
KR (1) KR870000958B1 (https=)
CA (1) CA1244012A (https=)
DE (1) DE3580293D1 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490339B1 (ko) * 2002-05-08 2005-05-17 국방과학연구소 2,2-디나이트로프로필 아크릴레이트와 2,2-디나이트로부틸아크릴레이트의 공중합체
US9745319B2 (en) 2013-03-15 2017-08-29 Araxes Pharma Llc Irreversible covalent inhibitors of the GTPase K-Ras G12C
UY35464A (es) 2013-03-15 2014-10-31 Araxes Pharma Llc Inhibidores covalentes de kras g12c.
TWI659021B (zh) 2013-10-10 2019-05-11 亞瑞克西斯製藥公司 Ｋｒａｓ ｇ１２ｃ之抑制劑
JO3556B1 (ar) 2014-09-18 2020-07-05 Araxes Pharma Llc علاجات مدمجة لمعالجة السرطان
US10011600B2 (en) 2014-09-25 2018-07-03 Araxes Pharma Llc Methods and compositions for inhibition of Ras
ES2826443T3 (es) 2014-09-25 2021-05-18 Araxes Pharma Llc Inhibidores de proteínas mutantes KRAS G12C
JP2018513853A (ja) 2015-04-10 2018-05-31 アラクセス ファーマ エルエルシー 置換キナゾリン化合物およびその使用方法
JP6789239B2 (ja) 2015-04-15 2020-11-25 アラクセス ファーマ エルエルシー Ｋｒａｓの縮合三環系インヒビターおよびその使用の方法
US10144724B2 (en) 2015-07-22 2018-12-04 Araxes Pharma Llc Substituted quinazoline compounds and methods of use thereof
EP3133065A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
WO2017058915A1 (en) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibitors of kras g12c mutant proteins
EP3356353A1 (en) 2015-09-28 2018-08-08 Araxes Pharma LLC Inhibitors of kras g12c mutant proteins
EP3356354A1 (en) 2015-09-28 2018-08-08 Araxes Pharma LLC Inhibitors of kras g12c mutant proteins
WO2017058807A1 (en) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibitors of kras g12c mutant proteins
WO2017058902A1 (en) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibitors of kras g12c mutant proteins
US10882847B2 (en) 2015-09-28 2021-01-05 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
US10647703B2 (en) 2015-09-28 2020-05-12 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
JP2018533939A (ja) 2015-10-19 2018-11-22 アラクセス ファーマ エルエルシー Ｒａｓの阻害剤をスクリーニングするための方法
KR20180081596A (ko) 2015-11-16 2018-07-16 아락세스 파마 엘엘씨 치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법
WO2017100546A1 (en) 2015-12-09 2017-06-15 Araxes Pharma Llc Methods for preparation of quinazoline derivatives
CN106986789B (zh) * 2016-01-20 2019-07-16 中国人民解放军军事医学科学院生物医学分析中心 对苯二酚类化合物及其制备方法与在抗肿瘤或免疫调节中的应用
WO2017172979A1 (en) 2016-03-30 2017-10-05 Araxes Pharma Llc Substituted quinazoline compounds and methods of use
US10646488B2 (en) 2016-07-13 2020-05-12 Araxes Pharma Llc Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
US10280172B2 (en) 2016-09-29 2019-05-07 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
EP3523289A1 (en) 2016-10-07 2019-08-14 Araxes Pharma LLC Heterocyclic compounds as inhibitors of ras and methods of use thereof
WO2018140514A1 (en) 2017-01-26 2018-08-02 Araxes Pharma Llc 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer
WO2018140599A1 (en) 2017-01-26 2018-08-02 Araxes Pharma Llc Benzothiophene and benzothiazole compounds and methods of use thereof
WO2018140513A1 (en) 2017-01-26 2018-08-02 Araxes Pharma Llc 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
CN110382482A (zh) 2017-01-26 2019-10-25 亚瑞克西斯制药公司 稠合的杂-杂二环化合物及其使用方法
EP3573954A1 (en) 2017-01-26 2019-12-04 Araxes Pharma LLC Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices
JP2020521741A (ja) 2017-05-25 2020-07-27 アラクセス ファーマ エルエルシー がんの処置のための化合物およびその使用の方法
US11639346B2 (en) 2017-05-25 2023-05-02 Araxes Pharma Llc Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
AU2018271990A1 (en) 2017-05-25 2019-12-12 Araxes Pharma Llc Covalent inhibitors of KRAS
MX2021000887A (es) 2018-08-01 2021-03-31 Araxes Pharma Llc Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer.
EP4015512A1 (en) * 2020-12-16 2022-06-22 AMO Ireland Optically active devices

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773063A (en) * 1956-12-04 Preparation of acrylamides
DE8498C (de) * Graf CH. DE MONTBLANC und L. GAULARD, Chemiker, in Paris Apparate zur Bereitung der sogenannten Ammoniak-Soda
DE312689C (https=) *
DE312687C (https=) *
US2773899A (en) * 1953-11-24 1956-12-11 Cilag Ltd Alkenoic amides of arylethers of alkanolamines
US3037056A (en) * 1959-03-30 1962-05-29 California Research Corp Amido polyglycols
US3280189A (en) * 1961-11-17 1966-10-18 Devoe & Raynolds Co Preparation of alcohol blocked n-hydroxymethyl unsaturated acid amides
NL288928A (https=) * 1962-02-14
NL293393A (https=) * 1962-06-04
NL302380A (https=) * 1962-12-22 1900-01-01
GB1010760A (en) * 1963-09-18 1965-11-24 Hercules Powder Co Ltd Modified polyolefines
DE1443912C3 (de) * 1964-12-08 1975-07-10 Bayer Ag, 5090 Leverkusen 3,5-Dialkyl-4-hydroxy-benzylamide der Acryl- bzw. Methacrylsäure und Verfahren zu ihrer Herstellung
US3627831A (en) * 1965-04-01 1971-12-14 Ciba Ltd Carboxylic acid amides
US3652478A (en) * 1967-10-27 1972-03-28 Mitsubishi Rayon Co Coating composition for electrodeposition coating
CH500168A (de) * 1968-04-19 1970-12-15 Basf Ag Verfahren zur Herstellung von Alkylenglykol-di(-acrylamid-N-methyl)-äthern
BE759428A (fr) * 1969-11-28 1971-04-30 Eastman Kodak Co Nouveaux composes acryliques monomeres et polymeres, utilisables en optique, et procede de preparation
US3796773A (en) * 1971-03-19 1974-03-12 Lubrizol Corp Graft polymers
US3784565A (en) * 1971-10-29 1974-01-08 Goodrich Co B F Stabilizers for chlorine-containing polymers
GB1415159A (en) * 1971-11-25 1975-11-26 Coates Bros Co Ltd Copolymers
US4233430A (en) * 1973-06-26 1980-11-11 L'oreal Anti-solar acrylamide derivative polymers, method of making the same and cosmetic compositions containing the same
US4025548A (en) * 1974-02-04 1977-05-24 The O'brien Corporation Radiation curable oligomers
US3928499A (en) * 1974-02-19 1975-12-23 Dow Chemical Co Unsaturated poly(amide-esters) and cross-linked derivatives thereof
CA1019485A (en) * 1974-06-21 1977-10-18 Sed Systems Ltd. Automatic dialing equipment
US4172933A (en) * 1975-07-16 1979-10-30 Xerox Corporation Polymers having pendant acceptor groups
US4021404A (en) * 1975-10-01 1977-05-03 The Goodyear Tire & Rubber Company Antihardeners for polymers
US4129545A (en) * 1976-01-16 1978-12-12 Mitsubishi Rayon Co., Ltd. Thermosetting acrylic copolymer usable as a powder paint and method for producing the same
US4134916A (en) * 1978-02-06 1979-01-16 Texaco Development Corp. N-polyalkoxyalkyl acrylamides or methacrylamides
US4393237A (en) * 1981-07-02 1983-07-12 Texaco Inc. Polyoxyalkylenepolyacrylamides

Also Published As

Publication number Publication date
DE3580293D1 (de) 1990-12-06
US4649219A (en) 1987-03-10
CA1244012A (en) 1988-11-01
EP0155177B1 (en) 1990-10-31
JPH0573739B2 (https=) 1993-10-15
KR870000958B1 (ko) 1987-05-14
EP0155177A2 (en) 1985-09-18
EP0155177A3 (en) 1987-02-04
KR850006924A (ko) 1985-10-25

Similar Documents

Publication Publication Date Title
JPS60193955A (ja) 環式不飽和アミド置換エ−テル化合物及びその製造方法
EP0028063B1 (en) Phenol derivatives, processes for their preparation and pharmaceutical compositions containing them
EP0054924A2 (en) Pharmaceutical compounds, their preparation and use
EP0901469B1 (en) Arylalkylpiperazine compounds as antioxidants
US4985585A (en) Phenoxyalkylcarboxylic acid derivatives and process for their preparations
EP0465802A1 (en) Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
CA2099294A1 (en) N-substituted anilines
JPH06211743A (ja) 置換された安息香酸
Gerzon et al. Structure-activity relationship of some diamine bis-epoxides in mouse leukaemia
EP0278414A2 (de) Verfahren zur Herstellung von Umsetzungsprodukten des 2,2-Bis (4-hydroxyphenyl) hexafluorpropans sowie solche neuen Derivate
EP1781297B1 (en) Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
EP0012824A1 (en) Process for the manufacture of alpha-tocopherol and novel intermediate in this process
US20070213336A1 (en) Biaromatic compound activators of ppargamma receptors and cosmetic/pharmaceutical compositions comprised thereof
EP0064445A1 (fr) Dialcoxy (2,4) benzènesulfonamides N-substitués
US3694489A (en) Pharmacologically active esters and amides of n-{8 3-trifluoromethylphenyl{9 -anthranilic acid
EP0064006B1 (fr) Chlorures de dialcoxy (2,4) benzènesulfonyle substitués
Oswald Organic Sulfur Compounds. II. Synthesis of Indanyl Aryl Sulfides, Sulfoxides, and Sulfones
CA1207770A (en) Anesthetic-antipuritic compounds
EP0343441A2 (de) Fluorierte Bis-aryloxy-substituierte Alkene, Verfahren zu deren Herstellung und deren Verwendung
US4701527A (en) Synthesis of salicylamides with improved reaction kinetics and improved effective yields
JPS60161942A (ja) 環式ハロゲン置換エ−テル化合物およびその製造方法
JPH01249739A (ja) オルトー脂肪族オキシフェノール誘導体の製造方法
WO1999005088A1 (en) Tamoxifen and analogues thereof
RAIFORD et al. THE ACTION OF NITROUS ACID ON THE BROMINE SUBSTITUTION PRODUCTS OF SOME PHENOLS
Sax The preparation of some aminosulphones and related compounds as potential pharmacological agents